News
LDC-backed Agentis Health Group launches with first acquisition
22 Sep 2025
Agentis Health Group (‘the Group’), a UK-based digital health management specialist, officially launches today with the acquisition of Living With, a leading digital health company specialising in condition-specific therapeutics and remote patient assessment, management and rehabilitation. This marks the Group’s first strategic move in bringing together the critical services needed to strengthen its digital therapeutics offer and transform long-term condition management for the NHS.
Established from within Ashtons – a leading UK provider of medicines management and prescribing technologies – the Group has been created to deliver better health outcomes for people living with long-term conditions. It will encompass three core service areas: Agentis Healthcare, Agentis Therapeutics and Agentis Diagnostics. Living With, along with Ashtons Virtual Hub and Primary Care Services, will sit within Agentis Healthcare.
With a focus on chronic conditions relevant to NHS primary care, such as heart failure, COPD and diabetes, Agentis Health Group brings together a unique blend of expertise across clinical and digital excellence, therapeutics and healthcare management, medicines management and diagnostics. With the offer of managing long-term condition pathways end-to-end, Agentis Health Group is building a single, scalable platform designed to help the NHS deliver smarter, more joined-up care.
Stephen Tuddenham, Chief Executive Officer of Agentis Health Group, said: “Over the past 40 years, Ashtons has proven the merits of a pharmacist-led approach to managing conditions and preventing ill health. Building on these strong foundations, we’ve engineered an organisation which is ideally structured to help address one of the most urgent challenges in NHS healthcare, and help the NHS deliver its ten-year plan to shift ‘from hospital to community, from analogue to digital, and from sickness to prevention’
Bringing Living With into our group means we can offer even more of what the NHS needs, all in one place. With our strong heritage, our expertise, and the acquisition of Living With, we’re hitting the ground running.”
“We’re excited about the next step in our journey,” said Chris Robson, CEO, Living With.
“Joining Agentis Health Group brings together Living With’s remote patient management and digital therapeutics platform with the Group’s medicines management, diagnostics, therapeutics, clinical and digital expertise. It creates a joined‑up, vertically integrated model for long‑term condition management that can help the NHS and other UK providers deliver the service transformation patients need. Above all, it unlocks the full potential of what we’ve built – giving us the scale, expertise and resources to grow faster, deliver more value for customers, and be an even better place to work.”
Ashtons will continue to serve more than 300 hospitals and care providers under the group’s specialist Agentis Therapeutics division, while the Agentis Healthcare division will focus on expanding the Group’s offer to NHS primary care, integrated care systems and commissioners. Agentis Diagnostics offers relevant testing and diagnostics services to both NHS and independent healthcare providers, supporting the end-to-end management of long-term-condition pathways. With this structure, Agentis Health Group is uniquely positioned to help the NHS achieve its long-term ambitions: improving health outcomes, enhancing patient experience, preventing ill health and easing frontline pressures.